Liisa Kanerva

Title: Liisa Kanerva: Innovator in Enzymatic Synthesis

Introduction

Liisa Kanerva is a notable inventor based in Littoinen, Finland. She has made significant contributions to the field of enzymatic synthesis, particularly in the pharmaceutical industry. Her innovative work has led to the development of a unique method for chiral resolution, which is crucial in the synthesis of various compounds.

Latest Patents

Liisa Kanerva holds a patent for her invention titled "Chiral resolution of an intermediate in diltiazem synthesis using lipase." This patent describes an enzymatic method for the preparation of (2S,3S)-threo-alkyl-2-hydroxy-3-(4-methoxyphenyl)-3-(2-X-phenylthio)propionate, where X can be various functional groups. The method utilizes a lipase that stereospecifically acylates the (2R,3R)-enantiomer of a racemic mixture. Following the enzymatic reaction, the (2S,3S)-enantiomer and the acylated (2R,3R)-compound are separated through techniques such as flash-chromatography or fraction crystallization.

Career Highlights

Liisa Kanerva is associated with Orion-Yhtyma Oy Fermion, where she applies her expertise in enzymatic processes. Her work has been instrumental in advancing the synthesis of pharmaceutical compounds, showcasing her innovative approach to problem-solving in the field.

Collaborations

Throughout her career, Liisa has collaborated with esteemed colleagues such as Pekka Kairisalo and Martti Hytonen. These collaborations have further enriched her research and contributed to the success of her projects.

Conclusion

Liisa Kanerva's contributions to enzymatic synthesis exemplify the impact of innovation in the pharmaceutical industry. Her patented methods not only enhance the efficiency of compound synthesis but also pave the way for future advancements in the field.